Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

This study has been completed.

Sponsored by:	Innovative Medical
Information provided by:	Innovative Medical
ClinicalTrials.gov Identifier:	NCT00483795

Purpose

To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.

Condition	Intervention	Phase
Corneal Staining	Drug: sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95	Phase IV

MedlinePlus related topics: Dietary Sodium

Drug Information available for: Propylene glycol Sodium chloride Citric acid Sodium Citrate Chlorides Sodium borate

Study Type:	Interventional
Study Design:	Randomized, Single Blind, Active Control, Parallel Assignment

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00483795

Locations

United States, Pennsylvania
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States, 18202

Sponsors and Collaborators

Innovative Medical

Investigators

Principal Investigator:

Thomas Kislan, OD

Hazleton Eye Specialists

More Information

Study ID Numbers:	5308
Study First Received:	June 1, 2007
Last Updated:	July 23, 2007
ClinicalTrials.gov Identifier:	NCT00483795
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Citric Acid

ClinicalTrials.gov processed this record on January 14, 2009